Cyclic AMP-regulated Synthesis of the Tissue Inhibitors of Metalloproteinases Suppresses the Invasive Potential of the Human Fibrosarcoma Cell Line HT1080

Kazuhiro Tanaka, Yukihide Iwamoto, Yasumasa Ito, Toru Ishibashi, Yusaku Nakabeppu, Mutsuo Sekiguchi, Yoichi Sugioka

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) play an important role in regulating the activity of matrix metalloproteinases (MMPs). Tumor cell Invasion and metastasis closely correlate with the activities of two members of MMPs, MMP2 and MMP9, both of which degrade type IV collagen in basement membranes. We herein report that the treatment of HT1060 ceus with 8-bromo-cAMP and other chemicals that activate cyclic adenylase activity induces the expression of TIMPl and TIMP2 both at the mRNA and the protein levels and that this induction of TIMPs correlates with suppression of invasive phenotypes of HT1080 cells. Treatment with various cAMP-elevating reagents induced the expression of TIMPs and MMP2 in HT1080 cells, whereas the expression of MMP9 was not significantly affected. The protein amounts of TIMP1, TIMP2, and MMP2 secreted into the medium from HT1080 cells treated with 1 mM 8-bromo-cAMP were 7.9-, 93-, and 8.5-fold higher than those secreted from untreated cells, respectively. Induction of these mRNAs by 8-bromo-cAMP was blocked by HA1004, a protein kinase A inhibitor, but not by calphostin C, a protein kinase C inhibitor. Cycloheximide abolished the induction of TIMPS and MMP2 mRNAs by 8-bromo-cAMP, indicating that the induction depends on a newly synthesized protein(s) whose expression may be regulated by cAMP. Type IV collagenolytic activity and the invasiveness of HT1080 cells, both of which were suppressed by 8-bromo-cAMP, were efficiently restored when the cells were exposed to anti-TIMP antibodies, demonstrating the importance of the increased levels of TIMP1 and TIMP2 proteins for the cAMP-mediated suppression of both type IV collagenolytic activity and the invasiveness of HT1080 cells.

Original languageEnglish
Pages (from-to)2927-2935
Number of pages9
JournalCancer Research
Volume55
Issue number13
Publication statusPublished - Jul 1 1995

Fingerprint

Tissue Inhibitor of Metalloproteinases
Fibrosarcoma
Cyclic AMP
8-Bromo Cyclic Adenosine Monophosphate
Cell Line
Protein Kinase Inhibitors
Matrix Metalloproteinases
Messenger RNA
Proteins
Collagen Type IV
Protein C Inhibitor
Cycloheximide
Cyclic AMP-Dependent Protein Kinases
Protein Kinase C
Neoplasm Metastasis
Phenotype
Antibodies

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Cyclic AMP-regulated Synthesis of the Tissue Inhibitors of Metalloproteinases Suppresses the Invasive Potential of the Human Fibrosarcoma Cell Line HT1080. / Tanaka, Kazuhiro; Iwamoto, Yukihide; Ito, Yasumasa; Ishibashi, Toru; Nakabeppu, Yusaku; Sekiguchi, Mutsuo; Sugioka, Yoichi.

In: Cancer Research, Vol. 55, No. 13, 01.07.1995, p. 2927-2935.

Research output: Contribution to journalArticle

Tanaka, Kazuhiro ; Iwamoto, Yukihide ; Ito, Yasumasa ; Ishibashi, Toru ; Nakabeppu, Yusaku ; Sekiguchi, Mutsuo ; Sugioka, Yoichi. / Cyclic AMP-regulated Synthesis of the Tissue Inhibitors of Metalloproteinases Suppresses the Invasive Potential of the Human Fibrosarcoma Cell Line HT1080. In: Cancer Research. 1995 ; Vol. 55, No. 13. pp. 2927-2935.
@article{59e7b076254c467f87afa59c85026493,
title = "Cyclic AMP-regulated Synthesis of the Tissue Inhibitors of Metalloproteinases Suppresses the Invasive Potential of the Human Fibrosarcoma Cell Line HT1080",
abstract = "Tissue inhibitors of metalloproteinases (TIMPs) play an important role in regulating the activity of matrix metalloproteinases (MMPs). Tumor cell Invasion and metastasis closely correlate with the activities of two members of MMPs, MMP2 and MMP9, both of which degrade type IV collagen in basement membranes. We herein report that the treatment of HT1060 ceus with 8-bromo-cAMP and other chemicals that activate cyclic adenylase activity induces the expression of TIMPl and TIMP2 both at the mRNA and the protein levels and that this induction of TIMPs correlates with suppression of invasive phenotypes of HT1080 cells. Treatment with various cAMP-elevating reagents induced the expression of TIMPs and MMP2 in HT1080 cells, whereas the expression of MMP9 was not significantly affected. The protein amounts of TIMP1, TIMP2, and MMP2 secreted into the medium from HT1080 cells treated with 1 mM 8-bromo-cAMP were 7.9-, 93-, and 8.5-fold higher than those secreted from untreated cells, respectively. Induction of these mRNAs by 8-bromo-cAMP was blocked by HA1004, a protein kinase A inhibitor, but not by calphostin C, a protein kinase C inhibitor. Cycloheximide abolished the induction of TIMPS and MMP2 mRNAs by 8-bromo-cAMP, indicating that the induction depends on a newly synthesized protein(s) whose expression may be regulated by cAMP. Type IV collagenolytic activity and the invasiveness of HT1080 cells, both of which were suppressed by 8-bromo-cAMP, were efficiently restored when the cells were exposed to anti-TIMP antibodies, demonstrating the importance of the increased levels of TIMP1 and TIMP2 proteins for the cAMP-mediated suppression of both type IV collagenolytic activity and the invasiveness of HT1080 cells.",
author = "Kazuhiro Tanaka and Yukihide Iwamoto and Yasumasa Ito and Toru Ishibashi and Yusaku Nakabeppu and Mutsuo Sekiguchi and Yoichi Sugioka",
year = "1995",
month = "7",
day = "1",
language = "English",
volume = "55",
pages = "2927--2935",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Cyclic AMP-regulated Synthesis of the Tissue Inhibitors of Metalloproteinases Suppresses the Invasive Potential of the Human Fibrosarcoma Cell Line HT1080

AU - Tanaka, Kazuhiro

AU - Iwamoto, Yukihide

AU - Ito, Yasumasa

AU - Ishibashi, Toru

AU - Nakabeppu, Yusaku

AU - Sekiguchi, Mutsuo

AU - Sugioka, Yoichi

PY - 1995/7/1

Y1 - 1995/7/1

N2 - Tissue inhibitors of metalloproteinases (TIMPs) play an important role in regulating the activity of matrix metalloproteinases (MMPs). Tumor cell Invasion and metastasis closely correlate with the activities of two members of MMPs, MMP2 and MMP9, both of which degrade type IV collagen in basement membranes. We herein report that the treatment of HT1060 ceus with 8-bromo-cAMP and other chemicals that activate cyclic adenylase activity induces the expression of TIMPl and TIMP2 both at the mRNA and the protein levels and that this induction of TIMPs correlates with suppression of invasive phenotypes of HT1080 cells. Treatment with various cAMP-elevating reagents induced the expression of TIMPs and MMP2 in HT1080 cells, whereas the expression of MMP9 was not significantly affected. The protein amounts of TIMP1, TIMP2, and MMP2 secreted into the medium from HT1080 cells treated with 1 mM 8-bromo-cAMP were 7.9-, 93-, and 8.5-fold higher than those secreted from untreated cells, respectively. Induction of these mRNAs by 8-bromo-cAMP was blocked by HA1004, a protein kinase A inhibitor, but not by calphostin C, a protein kinase C inhibitor. Cycloheximide abolished the induction of TIMPS and MMP2 mRNAs by 8-bromo-cAMP, indicating that the induction depends on a newly synthesized protein(s) whose expression may be regulated by cAMP. Type IV collagenolytic activity and the invasiveness of HT1080 cells, both of which were suppressed by 8-bromo-cAMP, were efficiently restored when the cells were exposed to anti-TIMP antibodies, demonstrating the importance of the increased levels of TIMP1 and TIMP2 proteins for the cAMP-mediated suppression of both type IV collagenolytic activity and the invasiveness of HT1080 cells.

AB - Tissue inhibitors of metalloproteinases (TIMPs) play an important role in regulating the activity of matrix metalloproteinases (MMPs). Tumor cell Invasion and metastasis closely correlate with the activities of two members of MMPs, MMP2 and MMP9, both of which degrade type IV collagen in basement membranes. We herein report that the treatment of HT1060 ceus with 8-bromo-cAMP and other chemicals that activate cyclic adenylase activity induces the expression of TIMPl and TIMP2 both at the mRNA and the protein levels and that this induction of TIMPs correlates with suppression of invasive phenotypes of HT1080 cells. Treatment with various cAMP-elevating reagents induced the expression of TIMPs and MMP2 in HT1080 cells, whereas the expression of MMP9 was not significantly affected. The protein amounts of TIMP1, TIMP2, and MMP2 secreted into the medium from HT1080 cells treated with 1 mM 8-bromo-cAMP were 7.9-, 93-, and 8.5-fold higher than those secreted from untreated cells, respectively. Induction of these mRNAs by 8-bromo-cAMP was blocked by HA1004, a protein kinase A inhibitor, but not by calphostin C, a protein kinase C inhibitor. Cycloheximide abolished the induction of TIMPS and MMP2 mRNAs by 8-bromo-cAMP, indicating that the induction depends on a newly synthesized protein(s) whose expression may be regulated by cAMP. Type IV collagenolytic activity and the invasiveness of HT1080 cells, both of which were suppressed by 8-bromo-cAMP, were efficiently restored when the cells were exposed to anti-TIMP antibodies, demonstrating the importance of the increased levels of TIMP1 and TIMP2 proteins for the cAMP-mediated suppression of both type IV collagenolytic activity and the invasiveness of HT1080 cells.

UR - http://www.scopus.com/inward/record.url?scp=0029043226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029043226&partnerID=8YFLogxK

M3 - Article

C2 - 7796421

AN - SCOPUS:0029043226

VL - 55

SP - 2927

EP - 2935

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 13

ER -